肝脏Dyrk1b通过调节Wbp2表达以依赖酶活性的方式损害了全身葡萄糖平衡
Lianju Li1,2, Yaoyu Zou3, Chongrong Shen1,2
1Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Heliyon
|September 19, 2024
概括
通过降低Wbp2蛋白水平,在肝脏中过度表达Dyrk1b会降低葡萄糖耐受性. 抑制Dyrk1b可以改善葡萄糖代谢,为代谢障碍揭示了一个新的治疗点.
科学领域:
- 生物化学 生物化学
- 代谢研究的研究.
- 分子生物学分子生物学
背景情况:
- 在Dyrk1b中获得功能的突变与高血糖 (FBG) 相关.
- 在葡萄糖代谢中Dyrk1b的确切作用仍然不完全理解.
- 了解Dyrk1b的功能对于代谢疾病研究至关重要.
研究的目的:
- 阐明Dyrk1b在肝脏葡萄糖代谢和胰岛素信号传递中的作用.
- 为了研究Dyrk1b影响葡萄糖平衡的分子机制.
- 评估针对代谢障碍的Dyrk1b的治疗潜力.
主要方法:
- 在小鼠模型中,肝Dyrk1b过度表达和切除.
- 关于胰岛素信号通路的体外研究.
- 定量蛋白质组分析以确定Dyrk1b相互作用的蛋白质.
- 系统葡萄糖耐受性和肝脏胰岛素信号的评估.
- 使用AZ191.1.使用Dyrk1b的药理抑制.
主要成果:
- 肝脏Dyrk1b过度表达导致小鼠的葡萄糖耐受性和胰岛素信号受损.
- Dyrk1b激酶活性对于其对葡萄糖平衡的作用至关重要.
- Dyrk1b 除改善了葡萄糖耐受性和胰岛素信号传递.
- 发现Dyrk1b通过无处不在和蛋白质酶体降解来下调WW域结合蛋白2 (Wbp2).
- 恢复Wbp2部分挽救了受损的葡萄糖平衡.
结论:
- 肝脏Dyrk1b通过对Wbp2.2的基因酶依赖调节损害了全身葡萄糖平衡.
- Dyrk1b代表了治疗葡萄糖代谢障碍的潜在治疗标.
- 向Dyrk1b可能为治疗代谢疾病提供一种新的策略.
相关概念视频
Cell Specific Gene Expression
13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K


